Collegium Pharmaceutical, Inc. (COLL)
22.02
+0.18
(+0.82%)
USD |
NASDAQ |
Oct 02, 16:00
22.05
+0.03
(+0.14%)
After-Hours: 20:00
Collegium Pharmaceutical Market Cap : 715.61M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 715.61M |
| October 01, 2026 | 709.76M |
| September 30, 2026 | 709.11M |
| September 29, 2026 | 722.44M |
| September 28, 2026 | 735.44M |
| September 25, 2026 | 732.19M |
| September 24, 2026 | 735.76M |
| September 23, 2026 | 729.59M |
| September 22, 2026 | 740.31M |
| September 21, 2026 | 748.76M |
| September 18, 2026 | 739.99M |
| September 17, 2026 | 727.31M |
| September 16, 2026 | 721.14M |
| September 15, 2026 | 709.76M |
| September 14, 2026 | 741.29M |
| September 11, 2026 | 739.34M |
| September 10, 2026 | 744.86M |
| September 09, 2026 | 759.16M |
| September 08, 2026 | 759.49M |
| September 04, 2026 | 764.68M |
| September 03, 2026 | 770.21M |
| September 02, 2026 | 789.71M |
| September 01, 2026 | 779.96M |
| August 31, 2026 | 799.78M |
| August 28, 2026 | 823.83M |
| Date | Value |
|---|---|
| August 27, 2026 | 859.26M |
| August 26, 2026 | 894.03M |
| August 25, 2026 | 892.73M |
| August 24, 2026 | 888.83M |
| August 21, 2026 | 881.03M |
| August 20, 2026 | 895.00M |
| August 19, 2026 | 934.00M |
| August 18, 2026 | 926.20M |
| August 17, 2026 | 912.23M |
| August 14, 2026 | 917.43M |
| August 13, 2026 | 914.83M |
| August 12, 2026 | 835.21M |
| August 11, 2026 | 844.31M |
| August 10, 2026 | 883.95M |
| August 07, 2026 | 957.72M |
| August 06, 2026 | 946.03M |
| August 05, 2026 | 1.161B |
| August 04, 2026 | 1.161B |
| August 03, 2026 | 1.153B |
| July 31, 2026 | 1.147B |
| July 30, 2026 | 1.166B |
| July 29, 2026 | 1.176B |
| July 28, 2026 | 1.163B |
| July 27, 2026 | 1.151B |
| July 24, 2026 | 1.141B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Innoviva, Inc. | 1.489B |
| Zevra Therapeutics, Inc. | 592.83M |
| ANI Pharmaceuticals, Inc. | 1.658B |
| Corcept Therapeutics, Inc. | 12.54B |
| Veru, Inc. | 42.80M |
Market Cap Related Metrics
| PE Ratio | 17.84 |
| PS Ratio | 1.036 |
| PEG Ratio | 0.9315 |
| Price to Book Value | 2.294 |
| Price to Free Cash Flow | 2.550 |
| Price | 22.02 |
| Earnings Yield | 5.61% |
| PEGY Ratio | 0.9315 |
| Operating PE Ratio | 5.148 |
| Normalized PE Ratio | 13.65 |